💨 Abstract

A Louisiana judge is set to hear arguments on a lawsuit challenging the state's new law classifying abortion-inducing drugs misoprostol and mifepristone as "controlled dangerous substances." Plaintiffs, including healthcare providers and individuals, argue that the reclassification could delay emergency treatments. The law, passed in 2024, aims to restrict access to these drugs, which are also used for reproductive health care.

Courtesy: wtop.com